Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)
Narasimha M. Beeraka, SubbaRao V. Tulimilli, Medha Karnik, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-20
Open Access | Times Cited: 20

Showing 20 citing articles:

Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein
Yuliu Chen, Yan Wu, Shaoying Chen, et al.
Journal of Virology (2022) Vol. 96, Iss. 24
Open Access | Times Cited: 23
Development of antibody resistance in emerging mutant strains of SARS CoV‐2: Impediment for COVID‐19 vaccines
Narasimha M. Beeraka, Olga Sukocheva, Elena Lukina, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 5
Open Access | Times Cited: 20
Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics
Kaifee Arman, Zeinab Dalloul, Esra Bozgeyik
Gene (2023) Vol. 861, pp. 147232-147232
Open Access | Times Cited: 11
Antibody Responses and CNS Pathophysiology of Mucormycosis in Chronic SARS Cov-2 Infection: Current Therapies Against Mucormycosis
Narasimha M. Beeraka, Junqi Liu, Olga Sukocheva, et al.
Current Medicinal Chemistry (2022) Vol. 29, Iss. 32, pp. 5348-5357
Closed Access | Times Cited: 3
Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19
Anna E. Boldova, Julia-Jessica D. Korobkin, Yury D. Nechipurenko, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 19, pp. 11364-11364
Open Access | Times Cited: 3
Herd immunity to SARS-COV-2 in the population of the Southern regions of the Far East of Russia
А. Yu. Popova, В. С. Смирнов, Е. Б. Ежлова, et al.
Acta Biomedica Scientifica (East Siberian Biomedical Journal) (2021) Vol. 6, Iss. 5, pp. 253-273
Open Access | Times Cited: 4
Comparative Pharmacological Efficacy of COVID-19 Vaccines against the Variants of Concerns (VOCs) of SARS-CoV-2: Recent Clinical Studies on Booster Dose
Di Zhao, Xiaoyan Wang, Junqi Liu, et al.
Current Pharmaceutical Biotechnology (2023) Vol. 24, Iss. 13, pp. 1603-1612
Closed Access | Times Cited: 1
A Biological Insight into the Susceptibility to Influenza Infection in Junior Rats by Comprehensive Analysis of lncRNA Profiles
Fen-Sheng Qiu, Hao-Kun Chen, Huazhong Ying, et al.
BioMed Research International (2021) Vol. 2021, pp. 1-9
Open Access | Times Cited: 2
The Concomitant Use o f Melatonin and Bebtelovimab as a Treatment Strategy for Omicron and Future Variants of Concern
Emine Erdag
International Journal Of Pharmaceutical Research And Allied Sciences (2022) Vol. 11, Iss. 4, pp. 33-40
Open Access | Times Cited: 1
Investigation d’un cas suspect de Manifestations Adverses Post Immunisation (MAPI) dans le district sanitaire de la Commune 6, Bamako, mai 2021
Ténin Traoré
Mali Santé Publique (2021), pp. 107-111
Open Access | Times Cited: 1
Management of COVID-19 Pneumonia: Experience in a Peripheral Tertiary Level Hospital in Bangladesh
Salam MU, A Goswami, S. Ahmad, et al.
The Journal of Sylhet Women’s Medical College (2023) Vol. 13, Iss. Number 2, pp. 97-105
Open Access
Amidst Cytokine Storm in Metabolic Diseases: Can 2-deoxy-D-glucose (2-DG) Cure COVID-19?
Shweta Shrivastava, Ayush Kumar, Manish Kumar Jeengar, et al.
Coronaviruses (2023) Vol. 5, Iss. 2
Closed Access
In Silico Structural-based Virtual Screening and Molecular Docking Analysis of Plant-derived Small Molecules for Treatment of COVID-19
Zahra Azadian, Kayhan Azadmanesh, Atefeh Alipour, et al.
Jundishapur Journal of Medical Sciences (2023) Vol. 21, Iss. 6, pp. 758-775
Open Access
Adverse Post-Vaccination Events (APEs) in Mali Hospital Following Astrazeneca COVID-19 Vaccine Immunization in Mali
Dicko Ousmane Attaher, Guediouma Dembélé, Dramé boubacar Sidiki Ibrahim, et al.
SAS Journal of Medicine (2022) Vol. 8, Iss. 3, pp. 143-149
Open Access
An Effective Platform for SARS-CoV-2 Prevention by Combining Neutralization and RNAi Technology
Junxiang Zhou, Xue Yin, Haojun Liang
Chinese Journal of Polymer Science (2022) Vol. 41, Iss. 3, pp. 327-333
Open Access
Modulating the Expression of Multiple Surface Receptors on Epithelial Cells and Promoting Lung Macrophage Anti-viral Functions by OM-85 Inhibits Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Niki Ubags, Christophe von Garnier
EMJ Respiratory (2022), pp. 67-76
Open Access
An Insight into the Immunomodulatory Effects of Probiotics in the Prevention of COVID-19 Disease
Jyotirmoy Das, Smita Bordoloi, Kalyani Pathak
Current Biotechnology (2022) Vol. 12, Iss. 1, pp. 14-24
Closed Access
Knowledge, Perceived Self-care Ability, and Health Behavior in New Normal Era among Adults in Congested Communities of Surabaya, Indonesia: Impacts of COVID-19 Pandemic Situation
Ni Putu Wulan Purnama Sari, Jintana Artsanthia
Journal of Educational Health and Community Psychology (2022) Vol. 11, Iss. 3, pp. 517-517
Open Access
Elucidating the pathogenicity, diagnosis, treatment, and prevention of COVID-19 – Part II
Monisha Parshotam Khatri, Sekar Mahalaxmi
SRM Journal of Research in Dental Sciences (2022) Vol. 13, Iss. 4, pp. 179-184
Closed Access
Tailored Nanoparticles as Vaccine Components
Alina Delia Popa, Sebastian Springer
Applied Sciences (2021) Vol. 11, Iss. 24, pp. 11898-11898
Open Access
Page 1

Scroll to top